BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 17287377)

  • 1. Differential medication adherence among patients with schizophrenia and comorbid diabetes and hypertension.
    Piette JD; Heisler M; Ganoczy D; McCarthy JF; Valenstein M
    Psychiatr Serv; 2007 Feb; 58(2):207-12. PubMed ID: 17287377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to antipsychotics and cardiometabolic medication: association with health care utilization and costs.
    Hansen RA; Maciejewski M; Yu-Isenberg K; Farley JF
    Psychiatr Serv; 2012 Sep; 63(9):920-8. PubMed ID: 22706887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive medication adherence in the Department of Veterans Affairs.
    Siegel D; Lopez J; Meier J
    Am J Med; 2007 Jan; 120(1):26-32. PubMed ID: 17208076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to Oral Medications for Hypertension and Diabetes in Veterans with Comorbid Airflow Limitation.
    Melzer AC; Uman J; Au DH
    Ann Am Thorac Soc; 2015 Jun; 12(6):831-7. PubMed ID: 25849224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does adherence to medications for type 2 diabetes differ between individuals with vs without schizophrenia?
    Kreyenbuhl J; Dixon LB; McCarthy JF; Soliman S; Ignacio RV; Valenstein M
    Schizophr Bull; 2010 Mar; 36(2):428-35. PubMed ID: 18718883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assertive community treatment in veterans affairs settings: impact on adherence to antipsychotic medication.
    Valenstein M; McCarthy JF; Ganoczy D; Bowersox NW; Dixon LB; Miller R; Visnic S; Slade EP
    Psychiatr Serv; 2013 May; 64(5):445-51, 451.e1. PubMed ID: 23412131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of daily dosing frequency on adherence to chronic medications among nonvalvular atrial fibrillation patients.
    Laliberté F; Nelson WW; Lefebvre P; Schein JR; Rondeau-Leclaire J; Duh MS
    Adv Ther; 2012 Aug; 29(8):675-90. PubMed ID: 22898791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic medication adherence: is there a difference between typical and atypical agents?
    Dolder CR; Lacro JP; Dunn LB; Jeste DV
    Am J Psychiatry; 2002 Jan; 159(1):103-8. PubMed ID: 11772697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of antihypertensive medications among United States veterans newly diagnosed with hypertension.
    Vincze G; Barner JC; Bohman T; Linn WD; Wilson JP; Johnsrud MT; Worchel J; Shepherd MD
    Curr Med Res Opin; 2008 Mar; 24(3):795-805. PubMed ID: 18252038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors related to antipsychotic oversupply among Central Texas Veterans.
    Yang M; Barner JC; Worchel J
    Clin Ther; 2007 Jun; 29(6):1214-25. PubMed ID: 17692735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission.
    Valenstein M; Copeland LA; Blow FC; McCarthy JF; Zeber JE; Gillon L; Bingham CR; Stavenger T
    Med Care; 2002 Aug; 40(8):630-9. PubMed ID: 12187177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to antipsychotic and nonpsychiatric medications in middle-aged and older patients with psychotic disorders.
    Dolder CR; Lacro JP; Jeste DV
    Psychosom Med; 2003; 65(1):156-62. PubMed ID: 12554828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using pharmacy data on partial adherence to inform clinical care of patients with serious mental illness.
    Woltmann EM; Valenstein M; Welsh DE; Lee TA; Wolschon PA; Grabowski J; Reilly PA
    Psychiatr Serv; 2007 Jun; 58(6):864-7. PubMed ID: 17535949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication regimen complexity in patients with uncontrolled hypertension and/or diabetes.
    Rettig SM; Wood Y; Hirsch JD
    J Am Pharm Assoc (2003); 2013; 53(4):427-31. PubMed ID: 23892818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of medication nonadherence among patients with diabetes in Medicare Part D programs: a retrospective cohort study.
    Yang Y; Thumula V; Pace PF; Banahan BF; Wilkin NE; Lobb WB
    Clin Ther; 2009 Oct; 31(10):2178-88; discussion 2150-1. PubMed ID: 19922889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychotropic prescribing in seriously violent men with schizophrenia or personality disorder in a UK high security hospital.
    Stone-Brown K; Naji M; Francioni A; Myers K; Samarendra H; Mushtaq-Chaudhry H; Heslop S; Sengupta S; Ross CC; Larkin F; Das M
    CNS Spectr; 2016 Feb; 21(1):60-9. PubMed ID: 26726766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of splitting risperidone tablets on medication adherence and on clinical outcomes for patients with schizophrenia.
    Weissman EM; Dellenbaugh C
    Psychiatr Serv; 2007 Feb; 58(2):201-6. PubMed ID: 17287376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescriber continuity and medication adherence for complex patients.
    Hansen RA; Voils CI; Farley JF; Powers BJ; Sanders LL; Sleath B; Maciejewski ML
    Ann Pharmacother; 2015 Mar; 49(3):293-302. PubMed ID: 25549627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When more is not better: treatment intensification among hypertensive patients with poor medication adherence.
    Heisler M; Hogan MM; Hofer TP; Schmittdiel JA; Pladevall M; Kerr EA
    Circulation; 2008 Jun; 117(22):2884-92. PubMed ID: 18506011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors.
    Valenstein M; Blow FC; Copeland LA; McCarthy JF; Zeber JE; Gillon L; Bingham CR; Stavenger T
    Schizophr Bull; 2004; 30(2):255-64. PubMed ID: 15279044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.